A hitherto undescribed disease characterized anatomically by deposits of fat and fattyacids in the intestinal and mesentericlymphatic tissues, Bull. Johns Hopkins Hosp, vol.18, p.382, 1907. ,
Combined electron and light microscopy in Whipple's disease. Demonstration of "bacillary bodies" in the intestine, Bull Johns Hopkins Hosp, vol.109, 1961. ,
Whipple's disease: new aspects of pathogenesis and treatment, Lancet Infect Dis, vol.8, p.179, 2008. ,
Whipple's arthritis. Joint, bone, spine : revue du rhumatisme, vol.83, 2016. ,
Value of Tropheryma whipplei quantitative polymerase chain reaction assay for the diagnosis of Whipple disease: usefulness of saliva and stool specimens for first-line screening, Clin Infect Dis, vol.47, 2008. ,
New insights into Whipple's disease and Tropheryma whipplei infections, Microbes Infect, vol.12, p.1102, 2010. ,
Whipple's disease, 1987. ,
, Lancet, vol.361, p.239, 2003.
Whipple's endocarditis: review of the literature and comparisons with Q fever, Bartonella infection, and blood culture-positive endocarditis, Clin Infect Dis, vol.33, p.1309, 2001. ,
Whipple endocarditis without overt gastrointestinal disease: report of four cases, Ann Intern Med, vol.131, 1999. ,
Clinical review of 52 cases. The SNFMI Research Group on Whipple Disease. Societe Nationale Francaise de Medecine Interne, Medicine (Baltimore), vol.76, 1997. ,
Ocular Whipple's disease: therapeutic strategy and long-term follow-up, Ophthalmology, vol.119, p.1465, 2012. ,
Ocular involvement in Whipple's disease: light and electron microscopic observations, Arch Ophthalmol, vol.96, p.1431, 1978. ,
Ocular manifestations of Whipple disease: an atypical presentation, Arch Ophthalmol, vol.116, p.1232, 1998. ,
Pulmonary manifestations of Whipple's disease. The Quarterly journal of medicine, vol.56, 1985. ,
Whipple disease revealed by lung involvement: a case report and literature review, Chest, vol.141, p.1595, 2012. ,
Whipple's disease presenting with lung involvement, Thorax, vol.51, p.343, 1996. ,
Whipple's disease: neurological relapse presenting as headache for two years, Journal of general internal medicine, vol.23, p.2131, 2008. ,
Clinical Manifestations, Treatment, and Diagnosis of Tropheryma whipplei Infections, Clin Microbiol Rev, vol.30, 2017. ,
Comment on: therapy for Whipple's disease, J Antimicrob Chemother, vol.61, p.968, 2008. ,
Whipple's disease, N Engl J Med, vol.356, 2007. ,
Infection: How should classic Whipple disease be managed?, Nat Rev Gastroenterol Hepatol, vol.7, p.246, 2010. ,
The combination of chloroquine and minocycline, a therapeutic option in cerebrospinal infection of Whipple's disease refractory to Références 69. B. Desnues, D. Raoult, J. L. Mege, IL-16 is critical for Tropheryma whipplei replication in Whipple's disease, J Immunol, vol.175, 2005. ,
IL-16 is constitutively present in peripheral blood monocytes and spontaneously released during apoptosis, J Immunol, vol.172, 2004. ,
IL-16 promotes T. whipplei replication by inhibiting phagosome conversion and modulating macrophage activation, PLoS One, vol.5, p.13561, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-02022462
Treatment of refractory Whipple disease with interferon-gamma, Ann Intern Med, vol.129, 1998. ,
Murine model of infection by Tropheryma whipplei, Infect Immun, vol.74, 2006. ,
Type I interferon induction is detrimental during infection with the Whipple's disease bacterium, Tropheryma whipplei, PLoS Pathog, vol.6, p.1000722, 2010. ,
Inborn errors of immunity to infection: the rule rather than the exception, J Exp Med, vol.202, 2005. ,
Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency, Proc Natl Acad Sci U S A, vol.113, p.8277, 2016. ,
Life-threatening infectious diseases of childhood: single-gene inborn errors of immunity?, Ann N Y Acad Sci, 2010. ,
Human genetics of infectious diseases: between proof of principle and paradigm, J Clin Invest, vol.119, p.2506, 2009. ,
Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFNgamma immunity, Semin Immunol, vol.26, p.454, 2014. ,
Pyogenic bacterial infections in humans with MyD88 deficiency, Science, vol.321, p.691, 2008. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01375224
Pyogenic bacterial infections in humans with IRAK-4 deficiency, Science, vol.299, p.2076, 2003. ,
Mendelian predisposition to herpes simplex encephalitis, Handbook of clinical neurology, vol.112, p.1091, 2013. ,
Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity, Clinical & translational immunology, vol.5, p.114, 2016. ,
Host genetics of severe influenza: from mouse Mx1 to human IRF7, Curr Opin Immunol, vol.38, 2016. ,
The human model: a genetic dissection of immunity to infection in natural conditions, Nat Rev Immunol, vol.4, 2004. ,
Human genetics of infectious diseases: a unified theory, EMBO J, vol.26, 2007. ,
-295 T-to-C promoter region IL-16 gene polymorphism is associated with Whipple's disease, Eur J Clin Microbiol Infect Dis, vol.34, 1919. ,
Association of asthma with a functional promoter polymorphism in the IL16 gene, J Allergy Clin Immunol, vol.117, 2006. ,
The -295T-to-C promoter polymorphism of the IL-16 gene is associated with Crohn's disease, Clin Immunol, vol.106, 2003. ,
Association of allergic contact dermatitis with a promoter polymorphism in the IL16 gene, J Allergy Clin Immunol, vol.112, p.1191, 2003. ,
The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple's disease, Gastroenterology, vol.136, p.2289, 2009. ,
, HLA B27 and defects in the T-cell system in Whipple's disease, vol.9, p.385, 1979.
HLA antigens in Whipple's disease, Arthritis Rheum, vol.3, 1987. ,
Class I and class II HLA antigens in a homogeneous Argentinian population with Whipple's disease: lack of association with HLA-B 27, Am J Gastroenterol, vol.86, 1991. ,
Lack of association with spondyloarthritis and HLA-B27 in Italian patients with Whipple's disease, The Journal of rheumatology, vol.28, 2001. ,
The human gene damage index as a gene-level approach to prioritizing exome variants, Proc Natl Acad Sci U S A, vol.112, p.13615, 2015. ,
Excess amino acid polymorphism in mitochondrial DNA: contrasts among genes from Drosophila, mice, and humans, Molecular biology and evolution, vol.13, 1996. ,
Biopython: freely available Python tools for computational molecular biology and bioinformatics, Bioinformatics, vol.25, p.1422, 2009. ,
Estimation of the neutrality index, Molecular biology and evolution, vol.28, 2011. ,
SnIPRE: selection inference using a Poisson random effects model, PLoS computational biology, vol.8, p.1002806, 2012. ,
A general framework for estimating the relative pathogenicity of human genetic variants, Nat Genet, vol.46, p.310, 2014. ,
IRF4: Immunity. Malignancy! Therapy? Clinical cancer research : an official journal of the American Association for, Cancer Research, vol.15, p.2954, 2009. ,
Crystal structure of PU.1/IRF-4/DNA ternary complex, Mol Cell, vol.10, p.1097, 2002. ,
Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers, EMBO J, vol.18, p.977, 1999. ,
Roles of interferon-regulatory factors in T-helper-cell differentiation, Nat Rev Immunol, vol.5, 2005. ,
Interferon regulatory factor subcellular localization is determined by a bipartite nuclear localization signal in the DNA-binding domain and interaction with cytoplasmic retention factors, Proc Natl Acad Sci U S A, vol.97, 2000. ,
IRF4 at the crossroads of effector T-cell fate decision, Eur J Immunol, vol.44, p.1886, 2014. ,
Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4, J Exp Med, vol.190, p.1837, 1999. ,
Interferon regulatory factor 4 negatively regulates the production of proinflammatory cytokines by macrophages in response to LPS, Proc Natl Acad Sci U S A, vol.102, p.16001, 2005. ,
Interleukin-4 induced interferon regulatory factor (Irf) 4 participates in the regulation of alternative macrophage priming, Immunobiology, vol.215, 2010. ,
Modulation of T cell cytokine production by interferon regulatory factor-4, J Biol Chem, vol.277, 2002. ,
Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression, J Exp Med, vol.195, p.1003, 2002. ,
A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma, Cancer cell, vol.12, 2007. ,
Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses, Nature, vol.458, p.351, 2009. ,
PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity, Molecular and cellular biology, vol.12, 1992. ,
,
IRF4 and IRF8: Governing the virtues of B Lymphocytes, Frontiers in biology, vol.9, 2014. ,
Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation, Nature communications, vol.4, p.2990, 2013. ,
The transcription factor PU.1 promotes alternative macrophage polarization and asthmatic airway inflammation, Journal of molecular cell biology, vol.7, p.557, 2015. ,
Compensatory dendritic cell development mediated by BATF-IRF interactions, Nature, vol.490, 2012. ,
BATF-JUN is critical for IRF4-mediated transcription in T cells, Nature, vol.490, 2012. ,
A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes, Science, vol.338, p.975, 2012. ,
Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4, Immunity, vol.38, 2013. ,
Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4, Proc Natl Acad Sci U S A, vol.99, p.11808, 2002. ,
Development of Th1 and not Th2 immune responses in mice lacking IFNregulatory factor-4, International immunology, vol.15, 2003. ,
The immunology of susceptibility and resistance to Leishmania major in mice, Nat Rev Immunol, vol.2, p.845, 2002. ,
Enhanced TCR-induced apoptosis in interferon regulatory factor 4-deficient CD4(+) Th cells, J Exp Med, vol.200, 2004. ,
Interferon regulatory factor 4 differentially regulates the production of Th2 cytokines in naive vs. effector/memory CD4+ T cells, Proc Natl Acad Sci U S A, vol.105, p.15890, 2008. ,
Th9 cell development requires a BATF-regulated transcriptional network, J Clin Invest, vol.123, p.4641, 2013. ,
Batf coordinates multiple aspects of B and T cell function required for normal antibody responses, J Exp Med, vol.207, p.933, 2010. ,
Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells, Immunity, vol.33, 2010. ,
The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation, Nat Immunol, vol.11, 2010. ,
Smad2/3 and IRF4 play a cooperative role in IL-9-producing T cell induction, J Immunol, vol.191, p.2360, 2013. ,
The transcription factor IFN regulatory factor-4 controls experimental colitis in mice via T cell-derived IL-6, J Clin Invest, vol.118, p.2415, 2008. ,
The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4, Nat Immunol, vol.8, p.958, 2007. ,
Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis, Scandinavian journal of immunology, vol.82, 2015. ,
Transcriptional regulation of T helper 17 cell differentiation, Yonsei medical journal, vol.51, 2010. ,
A validated regulatory network for Th17 cell specification, Cell, vol.151, p.289, 2012. ,
Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis, Immunity, vol.32, p.605, 2010. ,
Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation, Nature communications, vol.2, p.314, 2011. ,
IRF4 regulates IL-17A promoter activity and controls RORgammat-dependent Th17 colitis in vivo, Inflammatory bowel diseases, vol.17, p.1343, 2011. ,
,
Differentiation and function of Foxp3(+) effector regulatory T cells, Trends Immunol, vol.34, 2013. ,
, CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner, vol.326, p.986, 2009.
TCR signaling via Tec kinase ITK and interferon regulatory factor 4 (IRF4) regulates CD8+ T-cell differentiation, Proc Natl Acad Sci U S A, vol.109, p.2794, 2012. ,
IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis, J Clin Invest, vol.123, p.247, 2013. ,
The transcription factor IRF4 is essential for TCR affinity-mediated metabolic programming and clonal expansion of T cells, Nat Immunol, vol.14, p.1155, 2013. ,
The transcription factor Interferon Regulatory Factor 4 is required for the generation of protective effector CD8+ T cells, Proc Natl Acad Sci U S A, vol.110, p.15019, 2013. ,
Interferon regulatory factor 4 sustains CD8(+) T cell expansion and effector differentiation, Immunity, vol.39, p.833, 2013. ,
Graded levels of IRF4 regulate CD8+ T cell differentiation and expansion, but not attrition, in response to acute virus infection, J Immunol, vol.192, 2014. ,
Interferon regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre-B-cell receptor and promote cell-cycle withdrawal in pre-B-cell development, Blood, vol.111, p.1396, 2008. ,
A role for interferon regulatory factor 4 in receptor editing, Molecular and cellular biology, vol.28, p.2815, 2008. ,
Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination, Nat Immunol, vol.7, p.773, 2006. ,
Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation, J Immunol, vol.173, p.1158, 2004. ,
IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity, J Immunol, vol.174, p.2573, 2005. ,
Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation, Nat Immunol, vol.15, p.161, 2014. ,
IRF4 promotes cutaneous dendritic cell migration to lymph nodes during homeostasis and inflammation, J Immunol, vol.189, 2012. ,
IRF4 transcription-factor-dependent CD103(+)CD11b(+) dendritic cells drive mucosal T helper 17 cell differentiation, Immunity, vol.38, p.958, 2013. ,
IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses, Immunity, vol.38, p.970, 2013. ,
Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells, Immunity, vol.39, 2013. ,
Distinct Transcriptional Programs Control Cross-Priming in Classical and Monocyte-Derived Dendritic Cells, Cell reports, vol.15, p.2462, 2016. ,
The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting, Annu Rev Immunol, vol.31, p.563, 2013. ,
Differential expression of IFN regulatory factor 4 gene in human monocytederived dendritic cells and macrophages, J Immunol, vol.175, 2005. ,
Shared and distinct functions of the transcription factors IRF4 and IRF8 in myeloid cell development, PLoS One, vol.6, p.25812, 2011. ,
IRF-8 extinguishes neutrophil production and promotes dendritic cell lineage commitment in both myeloid and lymphoid mouse progenitors, Blood, vol.119, 2003. ,
,
Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function, J Leukoc Biol, vol.100, p.1273, 2016. ,
The cell biology of macrophage activation, Annu Rev Immunol, vol.2, p.283, 1984. ,
Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation, J Exp Med, vol.176, 1992. ,
M-1/M-2 macrophages and the Th1/Th2 paradigm, J Immunol, vol.164, p.6166, 2000. ,
Inflammatory monocytes recruited to allergic skin acquire an antiinflammatory M2 phenotype via basophil-derived interleukin-4, Immunity, vol.38, 2013. ,
Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis, J Exp Med, vol.204, p.1057, 2007. ,
URL : https://hal.archives-ouvertes.fr/inserm-00136917
Monocyte and macrophage heterogeneity in the heart, Circulation research, vol.112, p.1624, 2013. ,
Transcriptome-based network analysis reveals a spectrum model of human macrophage activation, Immunity, vol.40, 2014. ,
Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment, Cell, vol.159, p.1312, 2014. ,
Macrophage activation and polarization: nomenclature and experimental guidelines, Immunity, vol.41, 2014. ,
Conservation and divergence in Toll-like receptor 4-regulated gene expression in primary human versus mouse macrophages, Proc Natl Acad Sci U S A, vol.109, p.944, 2012. ,
Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences, Blood, vol.121, p.57, 2013. ,
Conservation and divergence in the transcriptional programs of the human and mouse immune systems, Proc Natl Acad Sci U S A, vol.110, p.2946, 2013. ,
The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection, Nat Immunol, vol.11, 2010. ,
Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammation, J Clin Invest, vol.126, 2016. ,
Baicalin ameliorates experimental inflammatory bowel disease through polarization of macrophages to an M2 phenotype, International immunopharmacology, vol.35, 2016. ,
Negative regulation of Toll-like-receptor signaling by IRF-4, Proc Natl Acad Sci U S A, vol.102, p.15989, 2005. ,
Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency, Science, vol.348, 2015. ,
IRF8 mutations and human dendritic-cell immunodeficiency, N Engl J Med, vol.365, 2011. ,
Functional characterization of the human dendritic cell immunodeficiency associated with the IRF8(K108E) mutation, Blood, vol.124, p.1894, 2014. ,
Biallelic mutations in IRF8 impair human NK cell maturation and function, J Clin Invest, vol.127, 2017. ,
Functional IRF3 deficiency in a patient with herpes simplex encephalitis, J Exp Med, vol.212, p.1371, 2015. ,
, Immunology. Autoimmunity by haploinsufficiency. Science, vol.345, p.1560, 2014.
BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiency, Nat Immunol, vol.18, 2017. ,
,
Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis, Immunity, vol.33, p.400, 2010. ,
IL-27 activates human monocytes via STAT1 and suppresses IL-10 production but the inflammatory functions of IL-27 are abrogated by TLRs and p38, J Immunol, vol.180, 2008. ,
STAT-1-mediated repression of monocyte interleukin-10 gene expression in vivo, Eur J Immunol, vol.36, issue.623, 2006. ,
Macrophage polarization in inflammatory diseases, International journal of biological sciences, vol.10, p.520, 2014. ,
Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin, Immunity, vol.39, p.925, 2013. ,
Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation, Immunity, vol.40, p.91, 2014. ,
Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice, Nat Immunol, vol.15, p.929, 2014. ,
In vitro differentiation of human macrophages with enhanced antimycobacterial activity, J Clin Invest, vol.121, 2011. ,
Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease, Nat Immunol, vol.12, 2011. ,
A primary human macrophage-enteroid co-culture model to investigate mucosal gut physiology and host-pathogen interactions, Scientific reports, vol.7, p.45270, 2017. ,
,
, Antoine Gu erin
,
,
,
,
,
,
,
,
Other infections Fifty-four (76%) patients had other bacterial and fungal infections caused by common microorganisms affecting children with CGD. The organisms most frequently isolated were Staphylococcus, Aspergillus, and Salmonella species, followed by Candida ,
, Fifty-eight (82%) patients are still alive, and their most recent
Chronic granulomatous disease, Annu Rev Med, vol.43, pp.117-141, 1992. ,
, J ALLERGY CLIN IMMUNOL, 2016.
Chronic granulomatous disease, Hematol Oncol Clin North Am, vol.27, pp.89-99, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00809510
Genetic, biochemical, and clinical features of chronic granulomatous disease, Medicine (Baltimore), vol.79, pp.170-200, 2000. ,
The human NADPH oxidase: primary and secondary defects impairing the respiratory burst function and the microbicidal ability of phagocytes, Scand J Immunol, vol.73, pp.420-427, 2011. ,
Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update), Blood Cells Mol Dis, vol.44, pp.291-300, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00809521
Hematologically important mutations: X-linked chronic granulomatous disease (third update), Blood Cells Mol Dis, vol.45, pp.246-65, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00809510
High-performance liquid chromatography under partially denaturing conditions (dHPLC) is a fast and cost effective method for screening molecular defects: four novel mutations found in X-linked chronic granulomatous disease ,
, Scand J Immunol, vol.76, pp.158-66, 2012.
Report on a national registry of 368 patients, Medicine (Baltimore), vol.79, pp.155-69, 2000. ,
Common severe infections in chronic granulomatous disease, Clin Infect Dis, vol.60, pp.1176-83, 2015. ,
Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease, Clin Infect Dis, vol.27, pp.1437-1478, 1998. ,
The BCG World Atlas: a database of global BCG vaccination policies and practices, PLoS Med, vol.8, p.1001012, 2011. ,
Bacillus Calmette-Guerin infection in NADPH oxidase deficiency: defective mycobacterial sequestration and granuloma formation, PLoS Pathog, vol.10, p.1004325, 2014. ,
BCG-osis and tuberculosis in a child with chronic granulomatous disease, J Allergy Clin Immunol, vol.120, pp.32-40, 2007. ,
Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients, J Allergy Clin Immunol, vol.132, pp.1156-63, 2013. ,
Susceptibility to mycobacterial infections in children with X-linked chronic granulomatous disease: a review of 17 patients living in a region endemic for tuberculosis, Pediatr Infect Dis J, vol.27, pp.224-254, 2008. ,
Successful unrelated cord blood stem cell transplantation in an X-linked chronic granulomatous disease patient with disseminated BCG-induced infection, Pediatr Neonatol, vol.56, pp.346-50, 2015. ,
A novel CYBB mutation with the first genetically confirmed case of chronic granulomatous disease in South Africa, S Afr Med J, vol.101, pp.768-777, 2011. ,
Mycobacterium tuberculosis meningitis as the first presentation of chronic granulomatous disease, Braz J Infect Dis, vol.16, pp.491-493, 2012. ,
Chronic granulomatous disease in Morocco: genetic, immunological, and clinical features of 12 patients from 10 kindreds, J Clin Immunol, vol.34, pp.452-460, 2014. ,
Hodgkin lymphoma in 2 children with chronic granulomatous disease, J Allergy Clin Immunol, vol.127, pp.1-3, 2011. ,
,
, Zhongguo Dang Dai Er Ke Za Zhi, vol.12, pp.490-493, 2010.
Genetic and mutational heterogeneity of autosomal recessive chronic granulomatous disease in Tunisia, J Hum Genet, vol.51, pp.887-95, 2006. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01375263
Alu-repeat-induced deletions within the NCF2 gene causing p67-phox-deficient chronic granulomatous disease (CGD), Hum Mutat, vol.31, pp.151-159, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00820713
X-linked chronic granulomatous disease: first report of mutations in patients of Argentina, J Pediatr Hematol Oncol, vol.26, pp.656-60, 2004. ,
Disseminated Mycobacterium flavescens in a probable case of chronic granulomatous disease, J Infect, vol.26, pp.83-89, 1993. ,
Clinical and laboratory aspects of chronic granulomatous disease in description of eighteen patients, Pediatr Allergy Immunol, vol.16, pp.5-9, 2005. ,
Diagnosis in a 27-year-old man with Mycobacterium fortuitum, JAMA, vol.233, pp.1295-1301, 1975. ,
Chronic Fusarium infection in an adult patient with undiagnosed chronic granulomatous disease, Clin Infect Dis, vol.37, pp.107-115, 2003. ,
Incidence, severity, and prevention of infections in chronic granulomatous disease, J Pediatr, vol.114, pp.555-60, 1989. ,
Molecular analysis of X-linked chronic granulomatous disease in five unrelated Korean patients, J Korean Med Sci, vol.19, pp.218-240, 2004. ,
Intrapulmonary Mycobacterium avium infection as the first manifestation of chronic granulomatous disease, J Infect, vol.34, pp.147-50, 1997. ,
Point mutations in the promoter region of the CYBB gene leading to mild chronic granulomatous disease, Clin Exp Immunol, vol.122, pp.410-417, 2000. ,
Pulmonary manifestations in adult patients with chronic granulomatous disease, Eur Respir J, vol.45, pp.1613-1636, 2015. ,
Diagnostic assays for chronic granulomatous disease and other neutrophil disorders, Methods Mol Biol, vol.412, pp.505-528, 2007. ,
Immunological conditions of children with BCG disseminated infection, Lancet, vol.346, p.581, 1995. ,
Disseminated Bacille Calmette-Guerin disease after vaccination: case report and review, Clin Infect Dis, vol.24, pp.1139-1185, 1997. ,
Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel, J Infect Dis, vol.205, issue.2, pp.199-208, 2012. ,
Bacillus Calmette Guerin triggers the IL-12/IFN-gamma axis by an IRAK-4-and NEMO-dependent, non-cognate interaction between monocytes, NK, and T lymphocytes, Eur J Immunol, vol.34, pp.3276-84, 2004. ,
Clinical and genotypic spectrum of chronic granulomatous disease in 71 Latin American patients: first report from the LASID registry, Pediatr Blood Cancer, vol.62, pp.2101-2108, 2015. ,
A novel X-linked recessive form of Mendelian susceptibility to mycobaterial disease, J Med Genet, vol.44, p.65, 2007. ,
Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease, Nat Immunol, vol.12, pp.213-234, 2011. ,
Phagocyte nicotinamide adenine dinucleotide phosphate oxidase activity in patients with inherited IFN-gammaR1 or IFN-gammaR2 deficiency, J Allergy Clin Immunol, vol.135, pp.1393-1398, 2015. ,
Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections, Cell Microbiol, vol.16, pp.1168-78, 2014. ,
Inheritance pattern and clinical aspects of 93 Iranian patients with chronic granulomatous disease, J Clin Immunol, vol.31, pp.792-801, 2011. ,
Chronic granulomatous disease: the European experience, PLoS One, vol.4, p.5234, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00382226
Inherited and acquired immunodeficiencies underlying tuberculosis in childhood, Immunol Rev, vol.264, pp.103-123, 2015. ,
IL-12Rbeta1 deficiency in two of fifty children with severe tuberculosis from Iran, PLoS One, vol.6, p.18524, 2011. ,
Revisiting human IL-12Rbeta1 deficiency: a survey of 141 patients from 30 countries, Medicine (Baltimore), vol.89, pp.381-402, 2010. ,
, J ALLERGY CLIN IMMUNOL, vol.138, issue.1
Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice, Tuber Lung Dis, vol.78, pp.237-283, 1997. ,
Impaired host defence against Mycobacterium avium in mice with chronic granulomatous disease, Clin Exp Immunol, vol.160, pp.457-60, 2010. ,
The role of nitric oxide in mycobacterial infections, Immune Netw, vol.9, pp.46-52, 2009. ,
BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies, J Allergy Clin Immunol, vol.133, pp.1134-1175, 2014. ,
, J ALLERGY CLIN IMMUNOL, 2016.